GoldBamboo.com - Knowledge is strong medicine
  

Chinese Community Smoking Cessation Project - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:






Colonic Diseases

Colonic Diseases (General) 




Clinical Trial: Chinese Community Smoking Cessation Project

This study is no longer recruiting patients.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00139516

Purpose

To test the efficacy of a culturally and linguistically tailored physician directed, nurse managed, smoking cessation and relapse prevention intervention among hospitalized Chinese smokers.
Condition Intervention
Cardiovascular Diseases
Heart Diseases
Lung Diseases
Diabetes Mellitus
Chronic Obstructive Pulmonary Disease
 Behavior: self-help
 Drug: nicotine replacement therapy

MedlinePlus related topics:  COPD (Chronic Obstructive Pulmonary Disease);   Diabetes;   Heart Diseases;   Respiratory Diseases;   Vascular Diseases

Study Type: Interventional
Study Design: Prevention, Randomized

Further Study Details: 

Study start: September 2001;  Study completion: August 2006

BACKGROUND:

Elements of effective in-hospital smoking cessation interventions include physician advice, bedside counseling, pharmacotherapy, post-discharge contacts and behavioral therapy with skill training. To date, little is known about successful smoking cessation strategies among ethnic minorities. Chinese Americans constitute the largest (23 percent) of the Asian American subgroup, numbering 1,645,472 in 1990. Their population growth is attributed mostly to immigration from China where there is an epidemic of smoking (74 percent prevalence). Thus, it is not surprisingly that reported smoking prevalence among Chinese immigrants in the US is as high as 55 percent.

The study was initiated in response to a Request for Applications issued in January, 2001 on " Overcoming Barriers to Treatment Adherence in Minorities and Persons Living in Poverty." The National Heart, Lung, and Blood Institute, the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Institute of Nursing Research invited applications for research project (R01) grants to evaluate interventions in clinical care settings designed to improve adherence to medically prescribed lifestyle and medical regimens used to treat heart, lung, blood or sleep diseases, disorders or conditions, cancer, or diabetes.

DESIGN NARRATIVE:

The four-year prospective, randomized clinical trial with 12 months follow-up, will test the efficacy of a culturally and linguistically tailored physician directed, nurse managed, smoking cessation and relapse prevention intervention among hospitalized Chinese smokers. The study has two aims: 1) To test the efficacy of the intervention among smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses; and 2) To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months. Patients who smoked in the 3 months prior to admission at 6 San Francisco Bay Area hospitals (1 university, 4 private and 1 county) will be screened, recruited and randomized to one of two interventions. The intensive condition (IC) will consist of a self-help brochure, physician advice, nicotine replacement therapy, face-to-face counseling, follow-up phone calls post-discharge and an additional phone call for relapsed smokers. The minimal condition (MC) consists of a self-help brochure and physician advice. Saliva continine will be used to verify cessation at 6 and 12 months.

Eligibility

Genders Eligible for Study:  Both
Criteria
No eligibility criteria

Location Information

Study chairs or principal investigators

Candice Wong,  University of California, San Francisco   

More Information

Study ID Numbers:  247
Last Updated:  August 30, 2005
Record first received:  August 29, 2005
ClinicalTrials.gov Identifier:  NCT00139516
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-13


[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Colonic Diseases.

November 27, 2009



Page Updated: October 3, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.